Literature DB >> 15458680

Sarcoid heart disease: clinical course and treatment.

Raed Bargout1, Russell F Kelly.   

Abstract

Sarcoidosis is a rare granulomatous disease of unknown etiology that can affect any organ. Cardiac involvement, although uncommon, has a wide spectrum of clinical manifestations and is potentially fatal. Although there is no agreement upon a strategy for the diagnosis (which is difficult to make based on clinical information alone), the introduction of newer technology is promising and may be useful both for the early diagnosis of cardiac involvement and for the evaluation of response to therapy. Early treatment is crucial in improving symptoms and prognosis. ICD implantation and cardiac transplantation may offer improvements in management, as steroid therapy and pacemaker implantation has led to improved outcomes over the past three decades.

Entities:  

Mesh:

Year:  2004        PMID: 15458680     DOI: 10.1016/j.ijcard.2003.07.024

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  25 in total

1.  Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.

Authors:  Robert Matthews; Travis Bench; Hong Meng; Dinko Franceschi; Nand Relan; David L Brown
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

2.  Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.

Authors:  Gautamy Chitiki Dhadham; Nishant Gupta; Rupen Parikh; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460

4.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

5.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

Review 6.  18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Authors:  Hicham Skali; Allison R Schulman; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Cardiac MRI in infiltrative disorders: a concise review.

Authors:  Neelima Penugonda
Journal:  Curr Cardiol Rev       Date:  2010-05

Review 9.  Pulmonary hypertension caused by sarcoidosis.

Authors:  Enrique Diaz-Guzman; Carol Farver; Joseph Parambil; Daniel A Culver
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

Review 10.  Sarcoid heart disease.

Authors:  Simon W Dubrey; Alex Bell; Tarun K Mittal
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.